Patents by Inventor William M. Kavanaugh

William M. Kavanaugh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • M-CSF specific monoclonal antibody and uses thereof
    Patent number: 9079956
    Abstract: M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.
    Type: Grant
    Filed: February 3, 2014
    Date of Patent: July 14, 2015
    Assignees: NOVARTIS VACCINES AND DIAGNOSTICS INC., XOMA TECHNOLOGY LTD.
    Inventors: Cheng Liu, Deborah Lee Zimmerman, Gregory Martin Harrowe, Kirston Koths, William M. Kavanaugh, Li Long, Maria Calderon-Cacia, Arnold Horwitz
  • SOLUBLE HUMAN M-CSF RECEPTOR AND USES THEREOF
    Publication number: 20150050280
    Abstract: Methods of using M-CSF antibodies to treat macrophage-associated diseases including atherosclerosis and HIV are provided.
    Type: Application
    Filed: June 20, 2014
    Publication date: February 19, 2015
    Inventor: William M. Kavanaugh
  • M-CSF SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF
    Publication number: 20140242071
    Abstract: M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.
    Type: Application
    Filed: February 3, 2014
    Publication date: August 28, 2014
    Applicants: XOMA TECHNOLOGY LTD., NOVARTIS VACCINES AND DIAGNOSTICS INC.
    Inventors: Cheng Liu, Deborah Lee Zimmerman, Gregory Martin Harrowe, Kirston Koths, William M. Kavanaugh, Li Long, Maria Calderon-Cacia, Arnold Horwitz
  • M-CSF-specific monoclonal antibody and uses thereof
    Patent number: 8652469
    Abstract: M-CSF-specific RX1-based or RX-I derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in or remodeling in a subject afflicted with an osteoblastic or osteolytic disease.
    Type: Grant
    Filed: July 27, 2006
    Date of Patent: February 18, 2014
    Assignees: Novartis AG, Xoma Technology Ltd.
    Inventors: William M. Kavanaugh, Lea Aukerman, Victoria Sung
  • METHOD FOR PREVENTING AND TREATING CANCER METASTASIS AND BONE LOSS ASSOCIATED WITH CANCER METASTASIS
    Publication number: 20120045450
    Abstract: M-CSF antagonists are used to prepare compositions, including pharmaceutical compositions, for preventing or treating cancer metastasis and/or bone loss associated with cancer metastasis in a mammal.
    Type: Application
    Filed: August 23, 2011
    Publication date: February 23, 2012
    Applicant: NOVARTIS AG
    Inventors: William M. Kavanaugh, Gregory M. Harrowe, Kirston Koths, Cheng Liu, Deborah L. Zimmerman
  • Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
    Publication number: 20110091451
    Abstract: M-CSF antagonists are used to prepare compositions, including pharmaceutical compositions, for preventing or treating cancer metastasis and/or bone loss associated with cancer metastasis in a mammal.
    Type: Application
    Filed: August 9, 2004
    Publication date: April 21, 2011
    Inventors: William M. Kavanaugh, Gregory M. Harrowe, Kirston Koths, Cheng Liu, Deborah L. Zimmerman
  • M-CSF-Specific Monoclonal Antibody and Uses Thereof
    Publication number: 20100092464
    Abstract: M-CSF-specific RX1-based or RX-I derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in or remodeling in a subject afflicted with an osteoblastic or osteolytic disease.
    Type: Application
    Filed: July 27, 2006
    Publication date: April 15, 2010
    Applicants: Novartis AG, XOMA Technology Ltd.
    Inventors: William M. Kavanaugh, Lea Auckerman, Victoria Sung
  • M-csf specific monoclonal antibody and uses thereof
    Publication number: 20090324604
    Abstract: M-CSF-specific antibody RX1 is provided, along with pharmaceutical compositions containing antibody RX1, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.
    Type: Application
    Filed: January 6, 2005
    Publication date: December 31, 2009
    Applicants: CHIRON CORPORATION, XOMA Technology Ltd.
    Inventors: Cheng Liu, Deborah Lee Zimmerman, Gregory M. Harrowe, Kirston Koths, William M. Kavanaugh, Li Long, Arnold Horwitz, Maria Calderon-Cacia
  • Uses Of Antibody To M-Csf
    Publication number: 20080233118
    Abstract: Methods of using M-CSF antibodies to treat macrophage-associated diseases including atherosclerosis and HIV are provided.
    Type: Application
    Filed: July 27, 2006
    Publication date: September 25, 2008
    Applicants: NOVARTIS AG, XOMA Technology Ltd.
    Inventor: William M. Kavanaugh